Blue Owl Capital Holdings »

Niocorp Devs shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Niocorp Devs (NIOBW) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Niocorp Devs

Tip: Access up to 7 years of quarterly data

All positions including Niocorp Devs held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Niocorp Devs by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $92k 767k 0.12

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Klaviyo Com Ser A (KVYO)
Tourmaline Bio (TRML)
Pliant Therapeutics (PLRX)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Proshares Tr Ultrapro Qqq (TQQQ)
Engene Holdings (ENGN)
Evercommerce (EVCM)
Acelyrin (SLRN)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord (RPTX)
Context Therapeutics (CNTX)
Ultragenyx Pharmaceutical (RARE)

View all positions for Blue Owl Capital Holdings

Top funds holding Niocorp Devs

Atalaya Capital Management
Blue Owl Capital Holdings
Corbin Capital Partners
Cowen And Company
Shaolin Capital Management
Jane Street
Calamos Advisors
Marshall Wace
Wolverine Asset Management
CNH Partners
Caas Capital Management
Arena Capital Advisors, LLC- CA
OMERS Administration Corporation
D. E. Shaw & Co
Tenor Capital Management

View all funds holding Niocorp Devs